Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 711

1.

Brain perfusion during rapid-eye-movement sleep successfully identifies amnestic mild cognitive impairment.

Brayet P, Petit D, Baril AA, Gosselin N, Gagnon JF, Soucy JP, Gauthier S, Kergoat MJ, Carrier J, Rouleau I, Montplaisir J.

Sleep Med. 2017 Jun;34:134-140. doi: 10.1016/j.sleep.2017.01.025. Epub 2017 Mar 30.

PMID:
28522082
2.

Suicide and assisted dying in dementia: what we know and what we need to know. A narrative literature review.

Diehl-Schmid J, Jox R, Gauthier S, Belleville S, Racine E, Schüle C, Turecki G, Richard-Devantoy S.

Int Psychogeriatr. 2017 May 2:1-13. doi: 10.1017/S1041610217000679. [Epub ahead of print]

PMID:
28462742
3.

Therapeutic efficacy of the Ginkgo special extract EGb761® within the framework of the mitochondrial cascade hypothesis of Alzheimer's disease.

Müller WE, Eckert A, Eckert GP, Fink H, Friedland K, Gauthier S, Hoerr R, Ihl R, Kasper S, Möller HJ.

World J Biol Psychiatry. 2017 May 2:1-17. doi: 10.1080/15622975.2017.1308552. [Epub ahead of print]

PMID:
28460580
4.

Defining Disease Activity and Response to Therapy in MS.

Kaunzner UW, Al-Kawaz M, Gauthier SA.

Curr Treat Options Neurol. 2017 May;19(5):20. doi: 10.1007/s11940-017-0454-5. Review.

PMID:
28451934
5.

Family history and APOE4 risk for Alzheimer's disease impact the neural correlates of episodic memory by early midlife.

Rajah MN, Wallace LMK, Ankudowich E, Yu EH, Swierkot A, Patel R, Chakravarty MM, Naumova D, Pruessner J, Joober R, Gauthier S, Pasvanis S.

Neuroimage Clin. 2017 Mar 31;14:760-774. doi: 10.1016/j.nicl.2017.03.016. eCollection 2017.

6.

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.

Ng KP, Pascoal TA, Mathotaarachchi S, Chung CO, Benedet AL, Shin M, Kang MS, Li X, Ba M, Kandiah N, Rosa-Neto P, Gauthier S; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2017 May 9;88(19):1814-1821. doi: 10.1212/WNL.0000000000003916. Epub 2017 Apr 12.

7.

Chitosan: A promising polymer for cartilage repair and viscosupplementation.

Comblain F, Rocasalbas G, Gauthier S, Henrotin Y.

Biomed Mater Eng. 2017;28(s1):S209-S215. doi: 10.3233/BME-171643.

PMID:
28372297
8.

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.

Ng KP, Pascoal TA, Mathotaarachchi S, Therriault J, Kang MS, Shin M, Guiot MC, Guo Q, Harada R, Comley RA, Massarweh G, Soucy JP, Okamura N, Gauthier S, Rosa-Neto P.

Alzheimers Res Ther. 2017 Mar 31;9(1):25. doi: 10.1186/s13195-017-0253-y.

9.

Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.

Wang Y, Spincemaille P, Liu Z, Dimov A, Deh K, Li J, Zhang Y, Yao Y, Gillen KM, Wilman AH, Gupta A, Tsiouris AJ, Kovanlikaya I, Chiang GC, Weinsaft JW, Tanenbaum L, Chen W, Zhu W, Chang S, Lou M, Kopell BH, Kaplitt MG, Devos D, Hirai T, Huang X, Korogi Y, Shtilbans A, Jahng GH, Pelletier D, Gauthier SA, Pitt D, Bush AI, Brittenham GM, Prince MR.

J Magn Reson Imaging. 2017 Mar 10. doi: 10.1002/jmri.25693. [Epub ahead of print] Review.

PMID:
28295954
10.

Recollection and familiarity in aging individuals: Gaining insight into relationships with medial temporal lobe structural integrity.

Schoemaker D, Mascret C, Collins DL, Yu E, Gauthier S, Pruessner JC.

Hippocampus. 2017 Jun;27(6):692-701. doi: 10.1002/hipo.22725. Epub 2017 Apr 10.

PMID:
28281326
11.

Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease.

Jia J, Gauthier S, Pallotta S, Ji Y, Wei W, Xiao S, Peng D, Guo Q, Wu L, Chen S, Kuang W, Zhang J, Wei C, Tang Y.

Alzheimers Dement. 2017 May;13(5):592-597. doi: 10.1016/j.jalz.2017.01.007. Epub 2017 Feb 24.

PMID:
28238739
12.

Incorporation of a platinum center in the pi-conjugated core of push-pull chromophores for nonlinear optics (NLO).

Durand RJ, Gauthier S, Achelle S, Kahlal S, Saillard JY, Barsella A, Wojcik L, Le Poul N, Robin-Le Guen F.

Dalton Trans. 2017 Feb 28;46(9):3059-3069. doi: 10.1039/c7dt00252a.

PMID:
28217794
13.

Multicenter Validation of an MMSE-MoCA Conversion Table.

Bergeron D, Flynn K, Verret L, Poulin S, Bouchard RW, Bocti C, Fülöp T, Lacombe G, Gauthier S, Nasreddine Z, Laforce RJ.

J Am Geriatr Soc. 2017 May;65(5):1067-1072. doi: 10.1111/jgs.14779. Epub 2017 Feb 15.

PMID:
28205215
14.

Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Ertz-Archambault N, Kosiorek H, Taylor GE, Kelemen K, Dueck A, Castro J, Marino R, Gauthier S, Finn L, Sproat LZ, Palmer J, Mesa RA, Al-Kali A, Foran J, Tibes R.

JAMA Oncol. 2017 Feb 2. doi: 10.1001/jamaoncol.2016.6435. [Epub ahead of print]

PMID:
28152123
15.

[18F]FDG PET signal is driven by astroglial glutamate transport.

Zimmer ER, Parent MJ, Souza DG, Leuzy A, Lecrux C, Kim HI, Gauthier S, Pellerin L, Hamel E, Rosa-Neto P.

Nat Neurosci. 2017 Mar;20(3):393-395. doi: 10.1038/nn.4492. Epub 2017 Jan 30.

PMID:
28135241
16.

Development of oriC-Based Plasmids for Mesoplasma florum.

Matteau D, Pepin ME, Baby V, Gauthier S, Arango Giraldo M, Knight TF, Rodrigue S.

Appl Environ Microbiol. 2017 Mar 17;83(7). pii: e03374-16. doi: 10.1128/AEM.03374-16. Print 2017 Apr 1.

PMID:
28115382
17.

No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study.

Kappos L, Havrdova E, Giovannoni G, Khatri BO, Gauthier SA, Greenberg SJ, You X, Wang P, Giannattasio G.

Mult Scler. 2016 Dec 1:1352458516683266. doi: 10.1177/1352458516683266. [Epub ahead of print]

PMID:
28080250
18.

Rapid whole brain myelin water content mapping without an external water standard at 1.5T.

Nguyen TD, Spincemaille P, Gauthier SA, Wang Y.

Magn Reson Imaging. 2017 Jun;39:82-88. doi: 10.1016/j.mri.2016.12.019. Epub 2017 Jan 7.

PMID:
28077267
19.

The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations.

Ismail Z, Agüera-Ortiz L, Brodaty H, Cieslak A, Cummings J, Fischer CE, Gauthier S, Geda YE, Herrmann N, Kanji J, Lanctôt KL, Miller DS, Mortby ME, Onyike CU, Rosenberg PB, Smith EE, Smith GS, Sultzer DL, Lyketsos C; NPS Professional Interest Area of the International Society of to Advance Alzheimer’s Research and Treatment (NPS-PIA of ISTAART)..

J Alzheimers Dis. 2017;56(3):929-938. doi: 10.3233/JAD-160979.

PMID:
28059789
20.

Synergistic interaction between amyloid and tau predicts the progression to dementia.

Pascoal TA, Mathotaarachchi S, Shin M, Benedet AL, Mohades S, Wang S, Beaudry T, Kang MS, Soucy JP, Labbe A, Gauthier S, Rosa-Neto P; Alzheimer's disease Neuroimaging Initiative..

Alzheimers Dement. 2016 Dec 23. pii: S1552-5260(16)33104-1. doi: 10.1016/j.jalz.2016.11.005. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center